The Perfect Enemy | Year: 2022 | Page 348
September 21, 2025

Year: 2022

Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use

F. Hoffmann-La Roche LtdBroad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights...